Stockreport

Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference [Yahoo! Finance]

Compass Therapeutics, Inc.  (CMPX) 
PDF developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced poster presentations on CTX-009, the Company's bispecific DLL4/VEGF- [Read more]